RAAP Cautions States Against Implementing 'Most Favored Nation' Drug Pricing Strategies The Rare Access Action Project (RAAP) has issued a cautionary policy paper warning states against adopting 'Most Favored Nation' drug pricing models, citing risks for patient access.

RAAP Cautions States Against Implementing 'Most Favored Nation' Drug Pricing Strategies #USA #Washington #Most_Favored_Nation #Rare_Access_Action_Project #Prescription_Drug_Affordability

Most Favored Nation Pricing Model May Hinder Patient Access to Medications A new brief by Apteka reveals that the Most Favored Nation pricing model could limit patient access to vital medications in the U.S.

Most Favored Nation Pricing Model May Hinder Patient Access to Medications #United_States #Washington #Drug_Pricing #Alliance_for_Patient_Access #Most_Favored_Nation